학술논문
Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group
Document Type
Article
Author
Source
In Annals of Oncology February 2020 31(2):246-256
Subject
Language
ISSN
0923-7534